Life Sciences

Investments in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. Between 2007 and 2012, global investment in R&D in the industry took a detour from US and Europe towards Asia-Pacific (APAC) countries, primarily targeting Australia, Singapore, and South Korea. This research report pre...

Indonesia has become one of the most attractive markets for investors during 2014-2015. Implementation of the Jaminan Kesehatan Nasional (JKN) scheme, initiated in January 2014, has been one of the major drivers besides the initiatives by the new government elected in 2014. As per the initial reports, patient volumes have significantly increased af...

The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and mic...

This research service provides the market revenues and trends of various breast imaging modalities in the Chinese market. Increasing incidence of breast cancer, awareness among the population, healthcare reforms, and expansion of breast screening to rural areas accelerate the growth of breast imaging market in China. Increasing disposable income, ...

The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...

This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...

Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...